MDLZ Latest Quarter's Earnings
| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $0.68 (Miss by $-0.016) |
| EPS GAAP Actual | $0.68 (Miss by $-0.016) |
| Revenue Actual | $10.496B |
| Revenue Surprise | Beat by $10496M |
Upcoming Quarter's Earnings
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.04577 |
| EPS GAAP Estimate | $1.04577 |
| Revenue Estimate | $10.063102944B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 4.0203 | 15.11 | 3.94187 | 4.14923 | 1 |
| Dec 2028 | 4.58038 | 13.26 | 4.50224 | 4.65689 | 4 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.52 | -0.38446 | 10.496B | 8.5% | 308.13M |
| FQ3 2025 (Sep 2025) | 0.57 | 0.57 | 9.744B | 5.54% | 9744M |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 8.984B | 7.13% | 8984M |
| FQ1 2025 (Mar 2025) | 0.31 | 0.31 | 9.313B | 0.25% | 9313M |
| FQ4 2024 (Dec 2024) | 1.31 | 1.31 | 9.604B | 3.02% | 9604M |
| FQ3 2024 (Sep 2024) | 0.64 | 0.64 | 9.204B | 1.9% | 9204M |
| FQ2 2024 (Jun 2024) | 0.45 | 0.45 | 8.343B | -1.97% | 8343M |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 9.29B | 1.33% | 9290M |
Quarterly Estimates Summary
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.04577
Consensus Revenue Estimates
10.063102944B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 0.9557 | -- | 0.91715 | 0.98337 | 5 |
| FQ2 2028 (Jun 2028) | 0.8097 | -- | 0.77704 | 0.83314 | 5 |
| FQ1 2028 (Mar 2028) | 0.8645 | -- | 0.82963 | 0.88953 | 5 |
| FQ4 2027 (Dec 2027) | 1.00098 | -- | 0.97524 | 1.03028 | 7 |
| FQ3 2027 (Sep 2027) | 0.95509 | -- | 0.94467 | 0.96937 | 8 |
| FQ2 2027 (Jun 2027) | 0.79904 | -- | 0.79033 | 0.81098 | 5 |
| FQ1 2027 (Mar 2027) | 0.87194 | -- | 0.86243 | 0.88497 | 4 |
| FQ4 2026 (Oct 2026) | 1.04201 | 50.1 | 1.00943 | 1.07797 | 9 |
| FQ3 2026 (Jul 2026) | 0.92625 | 38.46 | 0.89729 | 0.95821 | 9 |
| FQ2 2026 (Jun 2026) | 0.93788 | 47.75 | 0.90976 | 0.96077 | 4 |
| FQ1 2026 (Mar 2026) | 1.04577 | 70.36 | 1.01441 | 1.0713 | 4 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 10.62B | -- | 10.3B | 10.86B | 3 |
| FQ2 2028 (Jun 2028) | 9.72B | -- | 9.42B | 9.94B | 5 |
| FQ1 2028 (Mar 2028) | 10.3B | -- | 9.98B | 10.53B | 3 |
| FQ4 2027 (Dec 2027) | 11.24B | -- | 11.01B | 11.49B | 7 |
| FQ3 2027 (Sep 2027) | 10.14B | -- | 10.06B | 10.26B | 5 |
| FQ2 2027 (Jun 2027) | 9.21B | -- | 9.13B | 9.31B | 4 |
| FQ1 2027 (Mar 2027) | 10.16B | -- | 10.07B | 10.27B | 8 |
| FQ4 2026 (Oct 2026) | 10.07B | -4.27 | 9.82B | 10.33B | 5 |
| FQ3 2026 (Jul 2026) | 9.39B | -3.81 | 9.16B | 9.64B | 5 |
| FQ2 2026 (Jun 2026) | 9.36B | 4.03 | 9.15B | 9.54B | 4 |
| FQ1 2026 (Mar 2026) | 10.06B | 7.45 | 9.83B | 10.25B | 7 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.90446 | 0.52 | -0.38446 | -73.93% |
| FQ3 2025 (Sep 2025) | 0.57 | 0.57 | 100% | |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 100% | |
| FQ1 2025 (Mar 2025) | 0.31 | 0.31 | 100% | |
| FQ4 2024 (Dec 2024) | 1.31 | 1.31 | 100% | |
| FQ3 2024 (Sep 2024) | 0.64 | 0.64 | 100% | |
| FQ2 2024 (Jun 2024) | 0.45 | 0.45 | 100% | |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $10.19B | $10.5B | $308.13M | 2.94% |
| FQ3 2025 (Sep 2025) | $0B | $9.74B | $9744M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $8.98B | $8984M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $9.31B | $9313M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $9.6B | $9604M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $9.2B | $9204M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $8.34B | $8343M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $9.29B | $9290M | 100% |
MDLZ Ratings Summary
MDLZ Quant Ranking
